aTyr Pharma Inc (LIFE.OQ)

LIFE.OQ on NASDAQ Stock Exchange Global Select Market

2 Jul 2015
Change (% chg)

$-0.51 (-3.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for LIFE.OQ


aTyr Pharma, Inc. is a clinical-stage biotherapeutics company. The Company is engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using a set of physiological modulators. The Company has discovered approximately 300 Physiocrines, a class of naturally occurring proteins... (more)


Beta: --
Market Cap(Mil.): $389.73
Shares Outstanding(Mil.): 23.63
Dividend: --
Yield (%): --


  LIFE.OQ Industry Sector
P/E (TTM): -- 454.60 39.81
EPS (TTM): -1.22 -- --
ROI: -- -4.37 16.23
ROE: -- -5.27 17.36
Search Stocks

Thermo Fisher Q4 results top expectations on Life Tech buy

Jan 29 - Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, reported better-than-expected quarterly profit and sales, boosted by the contribution from the Life Technologies acquisition.

29 Jan 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
Provider: Reuters Investment Profile
Provider: MarketLine (a Datamonitor Company)
Provider: Wright Reports
Provider: S&P Capital IQ – STARS Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks